Abstract
Aim: HTX-019 (CINVANTI((R)) [aprepitant injectable emulsion]) is a neurokinin 1 receptor antagonist approved for preventing acute and delayed chemothe......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
